Longitudinal Blood Biomarkers Show Promise for Monitoring Alzheimer’s Disease Progression in Subjective Cognitive Decline

A prospective cohort study of 298 individuals with subjective cognitive decline (SCD) has found that longitudinal increases in plasma phosphorylated tau 217 (pTau217) and glial fibrillary acidic protein (GFAP) are strongly associated with…

Continue Reading